Us TOO in Seattle

Prostate Cancer Education, Support and Advocacy

Us TOO in Seattle Prostate Cancer Support Group meetings are open to men with prostate cancer, their loved ones, friends, and caregivers. Our goal is to provide comprehensive information on prostate cancer, its diagnoses, treatments, side effects, current research and other aspects that may be used to help us make informed decisions about the disease. Us TOO in Seattle monthly meetings offer peer-to-peer interaction and support, plus unbiased information from experts in areas related to prostate cancer including surgery, radiation, medication, psychology, healthy lifestyles, and more.

Spouses, partners, other family members and caregivers are welcome.

 Each Us TOO in Seattle meeting starts at 6pm with a facilitated discussion between participants followed by an educational presentation at 7pm by a healthcare provider or other speaker.  Meetings end promptly at 8:00.

Next Meeting  

Wednesday, May 25, 2022, 6 -8 pm online only

Guest speaker: Sara Sattler

Subject: Treatment side effects: urniary incontinence and erectile dysfunction

Sara Sattler is a sympathetic, engaging, knowledgeable, and impactful speaker on the topic of men's sexual health and the treatment options associated with prostate cancer. With her dynamic personality and candid approach, each speaking engagement replaces indifference and dismay with curiosity and hope. Sara works directly with patients and their partners who are experiencing the effects of erectile dysfunction either of organic or post-operative causes, providing a safe, educational and often humorous space for men to talk candidly about their challenges post prostate cancer.
Sara has spoken to patients, partners, doctors, groups, and vendors, coast to coast.

  

Join us via Zoom 

 

Future Meetings: 

Wednesday, June 22, 2022: 6:00 p.m.   - Molly Lanzinger will speak on choosing the right health insurance.

 

Dr. Michael Schweizer is an oncologist who specializes in treating patients with bladder, prostate and testicular cancers. His research focuses on developing new drugs and therapies to treat these cancers and to help speed advances from the lab into the clinic. He leads a number of innovative translational clinical trials, including studies evaluating high-dose testosterone as a therapeutic option for men with advanced prostate cancer.
Dr. Michael Schweizer is an oncologist who specializes in treating patients with bladder, prostate and testicular cancers. His research focuses on developing new drugs and therapies to treat these cancers and to help speed advances from the lab into the clinic. He leads a number of innovative translational clinical trials, including studies evaluating high-dose testosterone as a therapeutic option for men with advanced prostate cancer.
Dr. Michael Schweizer is an oncologist who specializes in treating patients with bladder, prostate and testicular cancers. His research focuses on developing new drugs and therapies to treat these cancers and to help speed advances from the lab into the clinic. He leads a number of innovative translational clinical trials, including studies evaluating high-dose testosterone as a therapeutic option for men with advanced prostate cancer.

 

 

Upcoming Events

Wednesday, Jun 22 at 6:00 PM - 8:00 PM
Wednesday, Jul 27 at 6:00 PM - 8:00 PM
Wednesday, Aug 24 at 6:00 PM - 8:00 PM
Wednesday, Sep 28 at 6:00 PM - 8:00 PM